AUTHORITIES are investigating the death of a second US woman to have died of a blood clot after she received the Johnson & Johnson vaccine.
The Oregon Health Authority is working with the Centers for Disease Control and Prevention after a woman developed a “rare but serious blood clot within two weeks following vaccination.”
The woman, in her 50s, received the Johnson & Johnson dose before the pause order on its use was issued.
It’s too early to tell if the vaccine had caused her death, read a press release from the OHA, which stressed an investigation is still underway.
“This blood clot was seen in combination with very low platelets,” the release read.
It added that “cases of this serious blood clot had been identified among six women around the country who received the vaccine,” before the pause was put into effect.
Health professionals and medical experts warned that the risk of developing a blood clot due to the Johnson & Johnson vaccine are very low.
“It’s an extraordinarily rare event,” said the nation’s leading infectious disease expert Dr. Anthony Fauci.
The nation has put the vaccine on pause as experts further investigate how it interacts with the body and its clotting mechanisms.
Over 130 million Americans have received at least one dose of the Covid-19 vaccine, with more than seven million receiving the Johnson & Johnson jab.
